Market cap
$4.4m
End-of-day close multiplied by current shares on issue.
MEE · NZX
Me Today (MEE)
Consumer / Wellness productsCovered: HY22 - HY269 published briefings
Me Today is an NZX-listed consumer / wellness products company with HY22 - HY26 of published result briefings.
Sections
Snapshot
Latest metrics
HY26, released 26 February 2026
← Swipe to view more
| Metric | Value | Change |
|---|---|---|
| Revenue | $2.6m | ↓ -31.7% |
| EBITDA | -$0.83m | ↑ +53.8% |
| NPAT | $3.2m | ↑ +233.3% |
| Operating cash flow | -$1m | ↑ +4.6% |
| OCF / EBITDA % | 120.8% | ↑ +62.3pp |
| Net debt | $0.02m | ↓ -99.8% |
| Net debt / EBITDA | n/m | — |
| ROE % | n/m | — |
| PBT | -$0.9m | ↑ +62.5% |
| FCF pre-lease | -$1.1m | ↓ -1.8% |
Source: latest published briefing (HY26, released 26 February 2026). Change compares against the prior equivalent period: HY25, released 28 February 2025.
Valuation
Valuation
A compact read on what the market price implies next to the latest filing data. The numbers are a starting point for comparison, not a recommendation.
Prices as at close, 30 July 2026
Price and market cap
The latest close and share count context for the market price.
i
Profitability multiples
How the market price compares with recent earnings and cash-flow inputs.
P/E
Not available
Not meaningful when recent earnings are negative.
EPS
-0.00
Recent filing-derived earnings per share.
PEG
Not available
Not available for this company right now.
EV/EBITDA
Not available
Not meaningful when recent EBITDA is negative.
P/FCF
Not available
Not meaningful when free cash flow is negative or unavailable.
P/B
1.45x
Market value compared with latest reported equity.
Income and fund shape
Yield and fund-style valuation where the company shape supports it.
Dividend yield
0.0%
Trailing dividends compared with the latest close.
Total return
Not available
Available once dividend and adjustment data are verified.
Chat
Ask about MEE
Ask follow-up questions about Me Today's latest result and company history.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Ask about MEE
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Longitudinal view
Performance over time
The latest period is shown first.
← Swipe to view more
| Metric | HY266 MONTHS26 February 2026 | FY2512 MONTHS28 August 2025 | HY256 MONTHS28 February 2025 | FY2412 MONTHS29 August 2024 | HY246 MONTHS28 February 2024 | FY2312 MONTHS29 August 2023 | HY236 MONTHS1 March 2023 | FY2112 MONTHS29 August 2022 | HY226 MONTHS29 November 2021 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.6m | $7.5m | $3.7m | $5m | $2.3m | $7.9m | $3.6m | $8.3m | $2.4m | Chart |
| Revenue growth % | -31.7% | 48.1%Outside range high revenue growth. 48.1%; 3-period range -36.2% to 14.7%. Revenue growth: 48.1%, above normal range; 3-period mean -8.8%, range -36.2%-14.7%. | 64.2% | -36.2%Outside range low revenue growth. -36.2%; 3-period range -4.7% to 48.1%. Revenue growth: -36.2%, below normal range; 3-period mean 19.3%, range -4.7%-48.1%. | -36.8%Outside range low revenue growth. -36.8%; 4-period range -31.7% to 469.6%. Revenue growth: -36.8%, below normal range; 4-period mean 137.8%, range -31.7%-469.6%. | -4.7% | 49.0% | 14.7% | 469.6%Unprecedented high revenue growth. 469.6%; 4-period range -36.8% to 64.2%. Revenue growth: 469.6%, unprecedented high; 4-period mean 11.2%, range -36.8%-64.2%. | Chart
|
| EBITDA | -$0.83m | -$4.8m | -$1.8m | -$4.5m | -$2.2m | -$5.2m | -$3.1m | -$5.7m | -$1.8m | Chart |
| EBITDA margin % | -32.4%Unprecedented high ebitda margin. -32.4%; 4-period range -97.7% to -47.9%. EBITDA margin: -32.4%, unprecedented high; 4-period mean -76.6%, range -97.7%--47.9%. | -63.8%Outside range high ebitda margin. -63.8%; 3-period range -89.1% to -65.2%. EBITDA margin: -63.8%, above normal range; 3-period mean -74.2%, range -89.1%--65.2%. | -47.9% | -89.1%Outside range low ebitda margin. -89.1%; 3-period range -68.3% to -63.8%. EBITDA margin: -89.1%, below normal range; 3-period mean -65.8%, range -68.3%--63.8%. | -97.7%Outside range low ebitda margin. -97.7%; 4-period range -85.4% to -32.4%. EBITDA margin: -97.7%, below normal range; 4-period mean -60.3%, range -85.4%--32.4%. | -65.3% | -85.4% | -68.3% | -75.6% | Chart
|
| PBT | -$0.9m | -$6m | -$2.4m | -$0.01m | -$7.3m | -$0.01m | -$5.8m | -$0.02m | -$2.8m | Chart |
| NPAT | $3.2m | -$6m | -$2.4m | -$0.01m | -$7.3m | -$0.01m | -$5.8m | -$0.02m | -$2.8m | Chart |
| Operating cash flow | -$1m | -$0.94m | -$1m | -$3.1m | -$1.9m | -$5.6m | -$4.6m | -$0.01m | -$4.6m | Chart |
| OCF / EBITDA % | 120.8% | 19.7% | 58.5% | 69.4% | 86.4% | 107.9% | 150.9% | 0.2% | 253.3% | Chart |
| FCF pre-lease | -$1.1m | -$0.94m | -$1.1m | -$3.1m | -$1.9m | -$5.6m | -$4.7m | -$0.01m | -$4.8m | Chart |
| ROE % | n/m | n/m | n/m | n/m | n/m | n/m | -30.5% | -81.1% | -9.9% | Chart |
| Net debt | $0.02m | $14.5m | $14m | $12.5m | $13.7m | $11.5m | $10m | $6.9m | $10.9m | Chart |
| Net debt / EBITDA | n/m | n/m | n/m | n/m | n/m | n/m | n/m | n/m | n/m | Chart |
| Debtor days | 114 | 67 | 91 | 103Outside range high debtor days. 103d; 3-period range 40d to 77d. Debtor days: 102.7 days, above normal range; 3-period mean 61.2 days, range 40.3 days-76.9 days. | 170Unprecedented high debtor days. 170d; 4-period range 86d to 145d. Debtor days: 170.4 days, unprecedented high; 4-period mean 108.9 days, range 86.2 days-144.6 days. | 77 | 86Outside range low debtor days. 86d; 4-period range 91d to 170d. Debtor days: 86.2 days, below normal range; 4-period mean 130.0 days, range 91.2 days-170.4 days. | 40Outside range low debtor days. 40d; 3-period range 67d to 103d. Debtor days: 40.3 days, below normal range; 3-period mean 82.1 days, range 66.6 days-102.7 days. | 145 | Chart
|
| Inventory days | 174Unprecedented low inventory days. 174d; 4-period range 655d to 1,658d. Inventory days: 173.7 days, unprecedented low; 4-period mean 1060.6 days, range 655.3 daysn/m days. | 548 | 655 | n/m | n/m | 684 | 791 | 741 | n/m | Chart
|
| Total assets | $6.6m | $15.2m | $19m | $21.5m | $20.7m | $27m | $33.9m | $39.5m | $46.2m | Chart |
Reference: annolyse.ai/companies/mee
Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.
Filing-only history charts
These charts use verified published filing periods only. Gaps are not interpolated, and mixed half-year/full-year histories are split into separate series.
Revenue
Reported revenue across covered periods.
Loading chart...
Revenue growth
Like-period revenue growth where comparable.
Loading chart...
- HY22 MEE HY: Unprecedented high revenue growth. 469.6%; 4-period range -36.8% to 64.2%. Revenue growth: 469.6%, unprecedented high; 4-period mean 11.2%, range -36.8%-64.2%.
- HY24 MEE HY: Outside range low revenue growth. -36.8%; 4-period range -31.7% to 469.6%. Revenue growth: -36.8%, below normal range; 4-period mean 137.8%, range -31.7%-469.6%.
- FY24 MEE FY: Outside range low revenue growth. -36.2%; 3-period range -4.7% to 48.1%. Revenue growth: -36.2%, below normal range; 3-period mean 19.3%, range -4.7%-48.1%.
- FY25 MEE FY: Outside range high revenue growth. 48.1%; 3-period range -36.2% to 14.7%. Revenue growth: 48.1%, above normal range; 3-period mean -8.8%, range -36.2%-14.7%.
EBITDA-equivalent
Company-specific earnings measure where disclosed.
Loading chart...
EBITDA margin
EBITDA-equivalent margin where revenue and earnings are source-backed.
Loading chart...
- HY24 MEE HY: Outside range low ebitda margin. -97.7%; 4-period range -85.4% to -32.4%. EBITDA margin: -97.7%, below normal range; 4-period mean -60.3%, range -85.4%--32.4%.
- HY26 MEE HY: Unprecedented high ebitda margin. -32.4%; 4-period range -97.7% to -47.9%. EBITDA margin: -32.4%, unprecedented high; 4-period mean -76.6%, range -97.7%--47.9%.
- FY24 MEE FY: Outside range low ebitda margin. -89.1%; 3-period range -68.3% to -63.8%. EBITDA margin: -89.1%, below normal range; 3-period mean -65.8%, range -68.3%--63.8%.
- FY25 MEE FY: Outside range high ebitda margin. -63.8%; 3-period range -89.1% to -65.2%. EBITDA margin: -63.8%, above normal range; 3-period mean -74.2%, range -89.1%--65.2%.
NPAT
Statutory profit after tax.
Loading chart...
Operating cash flow
Cash generated from operations.
Loading chart...
Full chartable metric set
Additional verified filing metrics for this company. Each point links back to a published briefing period in the source data contract.
FCF pre-lease
Operating cash flow less capex before leases.
Loading chart...
ROE
Return on equity.
Loading chart...
Net debt
Borrowings less cash; negative values indicate net cash.
Loading chart...
Debtor days
Receivables days where the working-capital inputs are source-backed.
Loading chart...
- HY23 MEE HY: Outside range low debtor days. 86d; 4-period range 91d to 170d. Debtor days: 86.2 days, below normal range; 4-period mean 130.0 days, range 91.2 days-170.4 days.
- HY24 MEE HY: Unprecedented high debtor days. 170d; 4-period range 86d to 145d. Debtor days: 170.4 days, unprecedented high; 4-period mean 108.9 days, range 86.2 days-144.6 days.
- FY21 MEE FY: Outside range low debtor days. 40d; 3-period range 67d to 103d. Debtor days: 40.3 days, below normal range; 3-period mean 82.1 days, range 66.6 days-102.7 days.
- FY24 MEE FY: Outside range high debtor days. 103d; 3-period range 40d to 77d. Debtor days: 102.7 days, above normal range; 3-period mean 61.2 days, range 40.3 days-76.9 days.
Inventory days
Inventory days where the working-capital inputs are source-backed.
Loading chart...
- HY26 MEE HY: Unprecedented low inventory days. 174d; 4-period range 655d to 1,658d. Inventory days: 173.7 days, unprecedented low; 4-period mean 1060.6 days, range 655.3 daysn/m days.
Operating working-capital movement
Per-period working-capital absorption or release, from the same published history. Positive values are working-capital build; negative values are release.
Loading chart...
- HY22 MEE: Outside range high operating working-capital movement. $14.7m; 3-period range $-1.1m to $1.4m. Operating working-capital movement: NZ$14.7m, above normal range; 1/3 prior periods had builds averaging NZ$1.4m, and 2 had releases averaging NZ$-1.0m.
- HY25 MEE: Outside range low operating working-capital movement. $-1.1m; 3-period range $-1m to $14.7m. Operating working-capital movement: NZ$-1.1m, below normal range; 2/3 prior periods had builds averaging NZ$8.0m, and 1 had releases averaging NZ$-1.0m.
The setup & the reality
FY25 → HY26 Follow-through
The latest result is checked against what the prior briefing said to watch.
Historical setup
What FY25 said to watch
Previous analysisFY25Result releasedAnnolyse analysis published
From Capital raise puts Me Today's debt headroom in focus
No quantitative targets were supplied. HY25 revenue of $3.7m represented 50.1% of the full year, implying an essentially flat second half on revenue but a heavier H2 EBITDA loss of about -$3.0m versus -$1.8m in H1. Operating cash flow swung from -$1.0m in H1 to roughly $0.1m positive in H2, again pointing to working-capital timing rather than improving underlying economics. Release commentary flags that a King Honey disposal will be reported in FY26, which will reshape the segment mix but is not reflected in current numbers.
Open questions
Open questions from FY25
- What level of EBITDA is achievable once the inventory release stops contributing and the King Honey segment is divested?
- How will negative equity be restored, and over what timeframe?
- Why did EBITDA deteriorate in the second half despite continued revenue scaling?
- What inventory level is sustainable for the continuing Me Today brand and agency businesses?
- What are the disclosed financial impacts of the planned King Honey disposal on FY26?
This briefing cannot assess going-concern conclusions, the commercial terms of the King Honey disposal, or the response of the major Chinese honey customer beyond what release commentary discloses.
Archive
Briefing archive
Every published Annolyse briefing for this company appears here in reverse chronological order.
HY26 · Released 26 February 2026
King Honey disposal flipped NPAT to NZ$3.2m while continuing revenue fell 31.7%
A NZ$4.1m discontinued-operation gain funded a balance-sheet reset, but continuing operations stayed loss-making on a sharply lower revenue base.
Read briefing
FY25 · Released 28 August 2025
Capital raise puts Me Today's debt headroom in focus
The NZ$2.6m capital raised is relevant to debt headroom, while borrowings and gearing remain the direct evidence.
Read briefing
HY25 · Released 28 February 2025
Losses narrowed 66.5% but equity fell to NZ$1.3m as debt rose
Revenue grew 64.2% and losses improved 66.5%, yet equity dropped 72.5% and cash conversion of 58.5% sits below the 152.9% historical mean.
Read briefing
FY24 · Released 29 August 2024
Revenue fell 36.2% on Honey collapse; EBITDA margin sank to -89.1%
China manuka demand weakness pushed revenue below the historical baseline, leaving equity of NZ$3.6m against NZ$15.4m of gross borrowings.
Read briefing
HY24 · Released 28 February 2024
Cash drained to zero, equity off 75.7% as MEE plans NZ$2.78m raise
EBITDA loss narrowed 27.7% but a customer write-down deepened the NPAT loss to NZ$7.3m and forced a debt restructure plan.
Read briefing
FY23 · Released 29 August 2023
Cash fell 83% to $0.9m despite PBT loss narrowing 41%
Losses narrowed materially, but a $5.6m operating cash burn left only $0.9m of cash against $12.4m of borrowings.
Read briefing
HY23 · Released 1 March 2023
Revenue rose 49% but PBT loss doubled to NZ$5.8m
Honey-led top-line growth produced negative operating leverage as the EBITDA loss widened and equity fell 32.4% to NZ$19.0m.
Read briefing
FY21 · Released 29 August 2022
Honey segment loss blew out to NZ$15.3m on 630-tonne stock overhang
Revenue rose 14.7% but a NZ$14.1m honey segment deterioration drove the PBT loss to NZ$22.1m even as a capital raise rebuilt cash.
Read briefing
HY22 · Released 29 November 2021
Honey pivot absorbed $14.7m of working capital and added $13.2m debt
Revenue grew 469.6% on a new honey segment, but inventory days hit 1,658 and operating cash outflow widened to $4.6m.
Read briefing
Get notified when MEE publishes
Get the next Me Today result briefing and five-year history updates by email.